To access this element change to forms mode OFF
Grant Award View - GA29796
A new therapeutic target for proteasome inhibitor resistant multiple...
GA ID:
GA29796
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$676,588.50
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
A new therapeutic target for proteasome inhibitor resistant multiple myeloma
Purpose:
Multiple myeloma (MM) is an incurable blood cancer for which novel therapeutic strategies are urgently required. Although MM patients have greatly benefited from the addition of the drug bortezomib to therapeutic regimens, resistance to bortezomib inevitably occurs. This proposal will examine ways to re-sensitise bortezomib-resistant MM by targeting lipid metabolism using new agents we have recently developed. By doing so, we hope to discover new therapies to extend the lives of MM patients.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1162954
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of South Australia
Recipient ABN:
37 191 313 308
Grant Recipient Location
Suburb:
Mawson Lake
Town/City:
Mawson Lake
Postcode:
5095
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, SA
Postcode:
Multiple
Country:
AUSTRALIA